SCN5A Variant N927S

Summary of observed carriers, functional annotations, and structural context for SCN5A N927S. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

4%

0/14 effective observations

Estimated BrS1 penetrance

54%

7/14 effective observations

Total carriers

4

4 BrS1 · 0 LQT3 · 0 unaffected

N927S has not been reported in gnomAD. This residue resides in a Hotspot region for Brugada syndrome and a Non_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 3 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-4.3 0 1.87 0.805 48 5

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
16764707 2006 1 0 1 0
21273195 2011 4 0 4 0
20129283 2010 1 0 1 0
20129283 2010 1 0 1 0
29325976 2018 2 0 2 0
30059973 2018 1 1 0 0
Literature, cohort, and gnomAD 4 0 0 4
Variant features alone 15 12 0 3

Totals may differ from individual publications due to duplicate patients removed during curation.

Functional data

Peak and late/persistent current values are relative to wild-type (100% indicates no change). V1/2 activation and inactivation denote the membrane potentials (mV) at which half-maximal current is achieved.

Published electrophysiology measurements.
PubMed ID Year Cell Type Peak Current (% WT) V1/2 Activation (mV) V1/2 Inactivation (mV) Late/Persistent Current (% WT)
16764707 2006
21273195 2011
20129283 2010
20129283 2010
29325976 2018
30059973 2018
32533946 2020 HEK 30

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near N927S.
Neighbour residue Distance (Å) Observed variants
891 11 I891N, I891T,
890 14 I890T,
919 12
896 7 C896S, C896S,
404 13 L404V, L404Q,
937 15
895 6 L895F,
1417 15
842 13
894 8 I894M,
247 13 V247L, V247L,
1455 14
254 14
372 12
401 13 S401P,
926 4
371 12 Q371E,
250 13
409 10 L409V, L409P,
928 4 L928P,
925 8 I925F,
366 12
934 11
1458 12 S1458Y,
933 10
246 13
935 10 L935P,
412 11 V412D,
897 7 G897R, G897R, G897E,
924 7 V924I,
927 0 N927S, N927K, N927K,
1466 15 c.4396_4397insG,
369 12 M369K,
845 14 c.2533delG,
1418 12
892 11 F892I,
373 15
1768 14 I1768V
849 11
898 11
893 12 R893C, R893H,
921 11
922 8 V922I,
405 9
1462 14
920 11
843 14 T843A,
900 15
930 7 c.2787+17_2787+18insACACACACACACACACACACACA, c.2788-6C>T,
1459 10 c.4376_4379delTCTT,
918 14
1454 13
410 14 A410V,
242 15 A242D,
929 7
413 14 A413T, A413E,
408 9
847 14
407 14
846 10 L846R,
367 15 R367C, R367H, R367L,
936 13
1416 15 c.4245+1G>A, c.4245+1G>C, c.4245+2T>A, A1416E, A1416G,
853 12
370 9 T370M,
923 5
406 12 N406S, N406K, N406K,
899 10
850 12 V850M, c.2549_2550insTG,
411 14 V411M,
243 12
932 6
931 5
1463 12 N1463Y,